Treatment options in early triple-negative breast cancer

SummaryWith a main focus on the early stage triple-negative breast cancer (TNBC), new data on immunotherapy in combination with chemotherapy, the role of capecitabine, the potential of circulating tumor DNA as a predictive tool in the postneoadjuvant setting and new treatment approaches were presented and disc ussed at the San Antonio Breast Cancer Symposium (SABCS) 2019.

http://link.springer.com/10.1007/s12254-020-00609-w

Source: Memo - Magazine of European Medical Oncology - May 6, 2020 Category: Cancer & Oncology Source Type: research